logo
Select company
Select metric
$ -212.39MEarning Before Interest & Taxes (EBIT)
VS
Market
5
Sector
9
Industry
11
History
22
$ 15.67Close
$ 5.56 - $ 16.49 52-Week Range
Ticker Information

Ticker

IMNM

Company Name

IMMUNOME INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

IMMUNOME INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IMNM - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -212.39M
3/31/2025$ -205.11M
12/31/2024$ -292.96M
9/30/2024$ -305.35M
6/30/2024$ -262.59M
3/31/2024$ -232.03M
12/31/2023$ -106.81M
9/30/2023$ -21.96M
6/30/2023$ -26.15M
3/31/2023$ -29.52M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IMMUNOME INC's latest trailing twelve months (TTM) EBIT stands at $ -17.8M.
  • Over the past 5 years, IMMUNOME INC's average EBIT has been $ -106.79M.
  • The median EBIT for IMMUNOME INC during this period was $ -36.52M
  • IMMUNOME INC reached its highest EBIT over the past 5 years at $ -17.8M.
  • The lowest EBIT recorded by IMMUNOME INC in the same timeframe $ -305.35M

IMMUNOME INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
NUVB : NUVATION BIO INC $ -202.21MQURE : UNIQURE NV $ -135.06MZBIO : ZENAS BIOPHARMA INC $ -176.76MTSHA : TAYSHA GENE THERAPIES INC $ -92.64MABUS : ARBUTUS BIOPHARMA CORP $ -54.14MPRAX : PRAXIS PRECISION MEDICINES INC $ -251.01MLENZ : LENZ THERAPEUTICS INC $ -51.9MCAPR : CAPRICOR THERAPEUTICS INC $ -69.98MRLAY : RELAY THERAPEUTICS INC $ -311.55MVIR : VIR BIOTECHNOLOGY INC $ -549.95M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

IMNM - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -305.35M

Minimum

Sep 30, 2024

$ -17.8M

Maximum

Dec 31, 2020

$ -106.79M

Average

$ -36.52M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.62M with a standard deviation of $ 130.62M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442.4M
average$ 28.62M
median$ 897.02K
std$ 130.62M